Sanofi (SNYNF) Gross Margin (2009 - 2026)

Sanofi (SNYNF) has 18 years of Gross Margin data on file, last reported at 77.13% in Q1 2026.

• Quarterly Gross Margin fell 85.0% year-over-year to 77.13% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 76.98% (down 96.0% YoY) and the FY2025 annual result came in at 77.17%, up 151.0% from the prior year.
• Gross Margin retreated to 77.13% in Q1 2026 per SNYNF's latest filing, from 81.66% in the prior quarter.
• The five-year high for Gross Margin was 83.31% in Q4 2024, with the low at 72.0% in Q4 2022.
• Average Gross Margin over 5 years is 76.35%, with a median of 76.02% recorded in 2024.
• Year-over-year, Gross Margin soared 853 bps in 2024 and tumbled 165 bps in 2025.
• Sanofi's Gross Margin stood at 72.0% in 2022, then climbed by 4 bps to 74.78% in 2023, then increased by 11 bps to 83.31% in 2024, then retreated by 2 bps to 81.66% in 2025, then slipped by 6 bps to 77.13% in 2026.
• Business Quant data shows SNYNF's Gross Margin at 77.13% in Q1 2026, 81.66% in Q4 2025, and 78.02% in Q3 2025.